Back to Questions
Question ID: WS-11
Submitted by: Liewei Wang
January 26, 2011
Comments
Question ID: WS-11
Submitted by: Liewei Wang
January 26, 2011
With the advancement of technology, genome wide association studies have been performed with regard to risk and treatment outcomes of cancer. Although the whole genome scan can expand our knowldege to the areas that are not known currently, we have not gained insights on the biology assoicated with these association studies. How can we move beyond biomarkers and use these information to help identify and understand novel biology and novel mechanisms? How to best use the technology to advance our understanding of cancer development and treatment? More studies need to be focused on the function and mechanisms in the post genomic era.
| This question has not yet been evaluated by users |
Comments
